Fresenius Medical Care AG & Co. KGaA ADR logo

Fresenius Medical Care AG & Co. KGaA ADR (FMEA)

Market Open
17 Aug, 13:45
XFRA XFRA
20. 20
-0.2
-0.9804%
- Market Cap
20.41 P/E Ratio
4.87% Div Yield
174 Volume
0 Eps
20.4
Previous Close
Add Transaction
Day Range
20.2 20.2
Year Range
17.2 23.6
Want to track FMEA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

FMEA trading today lower at €20.2, a decrease of -0.9804% from yesterday's close, completing a monthly increase of 3.0612% or €0.6. Over the past 12 months, FMEA stock gained 1%.
FMEA pays dividends to its shareholders, with the most recent payment made on Jun 08, 2026. The next estimated payment will be in In 9 months on Jun 08, 2027 for a total of €0.86435.
The last earnings report, released on May 04, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.35%, based on the last three reports.
Fresenius Medical Care AG & Co. KGaA ADR has completed 1 stock splits, with the recent split occurring on Dec 04, 2012.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NYSE (USD).

FMEA Chart

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

FMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.

Zacks | 1 week ago
Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript

Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript

Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript

Seekingalpha | 1 week ago
Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

Fresenius Medical Care AG & Co. KGaA NYSE: FMS reported second-quarter 2026 organic revenue growth of 5% and a 23% increase in operating income at constant currency, while confirming its full-year outlook despite weaker U.S. treatment volumes and anticipated reimbursement-related headwinds in the second half.

Marketbeat | 1 week ago

Fresenius Medical Care AG & Co. KGaA ADR (FMEA) FAQ

What is the stock price today?

The current price is €20.20.

On which exchange is it traded?

Fresenius Medical Care AG & Co. KGaA ADR is listed on XFRA.

What is its stock symbol?

The ticker symbol is FMEA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4.87%.

What is its market cap?

As of today, no market cap data is available.

Has Fresenius Medical Care AG & Co. KGaA ADR ever had a stock split?

Fresenius Medical Care AG & Co. KGaA ADR had 1 splits and the recent split was on Dec 04, 2012.

Fresenius Medical Care AG & Co. KGaA ADR Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Helen Giza CEO
XFRA Exchange
358029106 CUSIP
DE Country
108,165 Employees
22 May 2026 Last Dividend
4 Dec 2012 Last Split
- IPO Date

Overview

Fresenius Medical Care AG is a leading global provider in the field of dialysis and related services, catered towards individuals suffering from renal diseases. Established in 1996 and headquartered in Bad Homburg, Germany, the company has a broad reach extending across Germany, North America, and other international locations. Fresenius Medical Care AG specializes in delivering dialysis treatment and associated laboratory and diagnostic services mainly through its extensive network of outpatient dialysis clinics. Additionally, the company holds contracts with hospitals in the United States to offer dialysis services to hospitalized end-stage renal disease (ESRD) patients and those facing acute kidney failure. Beyond its core services, Fresenius Medical Care AG is engaged in the development, manufacture, and distribution of a wide range of health care products, as well as in the development and licensing of renal pharmaceuticals. It serves a diverse clientele, including dialysis clinics, hospitals, and specialized treatment facilities, through direct sales and a blend of local sales forces, independent distributors, dealers, and sales agents.

Products and Services

Fresenius Medical Care AG provides a comprehensive suite of products and services tailored to meet the needs of renal disease patients and health care providers:

  • Dialysis Services and Support: The company delivers dialysis treatment alongside laboratory and diagnostic services through its outpatient clinics. It also provides training, clinical monitoring, follow-up assistance, and home delivery of supplies for patients, alongside contracted dialysis services for hospitalized patients.
  • Health Care Products: The product line includes items such as polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, solutions, and granulates. These are essential for performing dialysis treatment both in clinics and at home.
  • Renal Pharmaceuticals: Fresenius Medical Care AG works on the development, acquisition, and in-licensing of renal pharmaceuticals. The company also supplies renal medications directly to patients' homes or dialysis clinics, ensuring that those undergoing treatment have easy access to their necessary medications.
  • Water Treatment Systems and Other Supplies: The comprehensive list of supplies includes bloodlines, hemodialysis concentrates, peritoneal dialysis solutions, and systems for water treatment, which ensure the safe conduct of dialysis treatment by managing the cleanliness and purity of water used.
  • Cardiopulmonary and Apheresis Products: Beyond renal care, the company also offers products for acute cardiopulmonary support and apheresis procedures, addressing the needs of patients with cardiovascular issues or those requiring blood purification.
  • Specialized Medical Services: Fresenius Medical Care AG provides additional specialized services, such as vascular, cardiovascular, and endovascular specialty services, ambulatory surgery center management for vascular care, and professional services for nephrology and cardiology. These are intended to complement the core dialysis services by addressing the broader health needs of renal disease patients.

Contact Information

Address: Else-KrOener Strasse 1
Phone: 49 6172 608 2522